
### [NCIT:C4536](http://purl.obolibrary.org/obo/NCIT_C4536)
**Label:** Pituitary Gland Carcinoma

**Subclasses:** [NCIT:C5965](http://purl.obolibrary.org/obo/NCIT_C5965) (TSH-Producing Pituitary Gland Carcinoma), [NCIT:C5962](http://purl.obolibrary.org/obo/NCIT_C5962) (Prolactin-Producing Pituitary Gland Carcinoma), [NCIT:C5963](http://purl.obolibrary.org/obo/NCIT_C5963) (Growth Hormone-Producing Pituitary Gland Carcinoma), [NCIT:C5964](http://purl.obolibrary.org/obo/NCIT_C5964) (ACTH-Producing Pituitary Gland Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C45934](http://purl.obolibrary.org/obo/NCIT_C45934) (HRAS Gene Mutation) 62.50%
- [NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome) 62.50%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 62.50%
- Thing 51.30%
- [NCIT:C45973](http://purl.obolibrary.org/obo/NCIT_C45973) (Malignant Adenohypophysial Cell) 34.86%
- [NCIT:C45963](http://purl.obolibrary.org/obo/NCIT_C45963) (Neoplastic Adenohypophysial Cell) 26.93%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 26.92%
- [NCIT:C36925](http://purl.obolibrary.org/obo/NCIT_C36925) (Neoplastic Endocrine Cell) 20.72%
- [NCIT:C36773](http://purl.obolibrary.org/obo/NCIT_C36773) (Adenocarcinoma Cell) 20.72%
- [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) 20.61%
- [NCIT:C36764](http://purl.obolibrary.org/obo/NCIT_C36764) (Abnormal Glandular Cell) 18.90%
- [NCIT:C36763](http://purl.obolibrary.org/obo/NCIT_C36763) (Neoplastic Glandular Cell) 18.90%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 17.96%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) 16.95%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) 16.94%


